期刊
UROLOGIC CLINICS OF NORTH AMERICA
卷 33, 期 2, 页码 201-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ucl.2005.12.010
关键词
-
资金
- NIDDK NIH HHS [R01 DK60957, R01 DK059142] Funding Source: Medline
Advanced and metastatic prostate cancers remain potentially lethal tumors. Although androgen deprivation therapy remains the most effective treatment, patients who progress to androgen independence die of their disease. This article focuses on the mechanisms by which hormone resistance develops, including the reactivation of androgen receptor during androgen deprivation therapy, the role of cancer stem cells, and the emergence of epithelial-mesenchymal transition cells, which have increased metastatic potential. It is through an enhanced understanding of these mechanisms that new therapies can be developed to combat this disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据